BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1291042)

  • 1. [A screening program for the diagnosis of early forms of prostatic carcinoma].
    Zvara P; Hornák M
    Bratisl Lek Listy; 1992 Nov; 93(11):585-8. PubMed ID: 1291042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis of prostate cancer in the Western Cape.
    Heyns CF; Naudé AM; Visser AJ; Marais DC; Stopforth HB; Nyarko JK; Stellmacher GA
    S Afr Med J; 2001 Aug; 91(8):679-84. PubMed ID: 11584784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality-of-life outcomes for men with prostate carcinoma detected by screening.
    Smith DS; Carvalhal GF; Schneider K; Krygiel J; Yan Y; Catalona WJ
    Cancer; 2000 Mar; 88(6):1454-63. PubMed ID: 10717630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
    Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
    J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer: a urological perspective.
    Fradet Y
    Can J Oncol; 1994 Nov; 4 Suppl 1():8-12. PubMed ID: 8853480
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of screening in detection of clinically localized prostate cancer.
    Galić J; Karner I; Cenan L; Tucak A; Vranjes Z; Bilandzija-Peranović M; Hegedus I
    Coll Antropol; 2003; 27 Suppl 1():49-54. PubMed ID: 12955891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district.
    Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for prostate cancer in a population of South Poland--studies 2000.
    Laskiewicz J; Janik A; Dobrek Ł; Słodowska-Hajduk Z; Matyja A; Thor PJ
    Folia Med Cracov; 2003; 44(1-2):159-68. PubMed ID: 15232898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate-specific antigen in the diagnosis of organ-confined treatable prostate carcinoma].
    Recker F
    Schweiz Med Wochenschr; 1996 Nov; 126(44):1881-90. PubMed ID: 8984601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of urological and male genital tumors diagnosed in Beijing Hospital 1995 - 2004].
    Liu M; Wang JY; Zhang YG; Zhu SC; Lu ZH; Wan B
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2423-5. PubMed ID: 18036323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of prostate cancer patients detected by prostate-specific antigen-based population screening in Kanazawa City, Japan.
    Kitagawa Y; Mizokami A; Nakashima K; Koshida K; Shimamura M; Miyazaki K; Koyama N; Namiki M
    Int J Urol; 2011 Aug; 18(8):592-6. PubMed ID: 21679256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer: the new evidence base for diagnosis and treatment.
    Lamb DS; Slaney D; Smart R; Nacey JN; Russell G; Scott B; Johnson CA; Adams JD; Moran S; Delahunt B
    Pathology; 2007 Dec; 39(6):537-44. PubMed ID: 18027255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
    Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
    Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA and the family physician.
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():20-3. PubMed ID: 21501547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of clinically localized prostate cancer. Part I--observation or treatment?].
    Szelachowska J; Kornafel J; Gisterek I
    Pol Merkur Lekarski; 2006 Dec; 21(126):594-7. PubMed ID: 17405305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma.
    Hugosson J; Aus G; Lilja H; Lodding P; Pihl CG
    Cancer; 2004 Apr; 100(7):1397-405. PubMed ID: 15042673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An experience of individual and early diagnosis of prostate cancer in a Tunisian centre].
    Khouaja K; Ben Sorba N; Bouslama A; Youssef A; Taher Mosbah A
    Prog Urol; 2005 Apr; 15(2):255-9. PubMed ID: 15999603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate carcinoma among men with human immunodeficiency virus infection.
    Crum NF; Spencer CR; Amling CL
    Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of prostate cancer. Recommendations from the Canadian Urological Association.
    Ramsey EW
    Can J Oncol; 1994 Nov; 4 Suppl 1():82-5. PubMed ID: 8853498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.